Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.

Information

  • Research Project
  • 10239076
  • ApplicationId
    10239076
  • Core Project Number
    R01AI145645
  • Full Project Number
    5R01AI145645-04
  • Serial Number
    145645
  • FOA Number
    PA-17-113
  • Sub Project Id
  • Project Start Date
    9/1/2019 - 4 years ago
  • Project End Date
    8/31/2023 - 9 months ago
  • Program Officer Name
    D'SOUZA, PATRICIA D
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    04
  • Suffix
  • Award Notice Date
    9/14/2021 - 2 years ago
Organizations

Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.

PROJECT SUMMARY/ABSTRACT There is an abundance of evidence demonstrating the importance of Fc-mediated effector function to the overall activity of an antibody in vivo. However, the relative contribution of virus neutralization versus effector functions to the antiviral effect of an antibody remains undefined. We have proposed a series of experiments that will quantify the contributions of Fc-mediated effector functions to the overall activity of an antibody. The quantitative experiments will be performed in the setting of antibody treatment of SHIV infection in rhesus macaques. These fundamental questions in immunology have yet to be answered, and the resultant information promises to provide important insights on how the two major properties (neutralization versus effector functions) of a vaccine- induced IgG response combine forces to ward off the establishment of HIV infection.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    226190
  • Indirect Cost Amount
    21557
  • Total Cost
    247747
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIAID:247747\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    HIVD
  • Study Section Name
    HIV Immunopathogenesis and Vaccine Development Study Section
  • Organization Name
    COLUMBIA UNIVERSITY HEALTH SCIENCES
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    621889815
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    100323725
  • Organization District
    UNITED STATES